Protagonist Therapeutics, Inc (PTGX) › Shares OutstandingProtagonist Therapeutics, Inc (PTGX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 272.4K2016: 16.72M2017: 21.09M2018: 23.19M2019: 27.22M2020: 43.75M2021: 47.84M2022: 49.34M2023: 57.71M2024: 61.04M2025: 62.58M62.58M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202562.58M+2.5%202461.04M+5.8%202357.71M+17.0%202249.34M+3.1%202147.84M+9.4%202043.75M+60.7%201927.22M+17.4%201823.19M+10.0%201721.09M+26.1%201616.72M+6038.7%2015272.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share